Literature DB >> 25083423

Prognostic value of different amounts of cancer stem cells in different molecular subtypes of breast cancer.

Guohua Yang1, Fangqing Xue1, Xiaogeng Chen1.   

Abstract

OBJECTIVE: To investigate the differences in the amount of cancer stem cells in different breast cancer subtypes.
METHODS: THE SPECIMENS OF BREAST CANCER TISSUES WERE DIVIDED INTO FIVE GROUPS: group A (luminal A type), B (luminal B type), C (HER-2 + type), D (basal-like type) and E (normal-like type) according to their molecular subtypes. The cancer stem cell spheres in each group were measured through colony formation method, and then the relations of the amount of cancer stem cells with the subtypes of breast cancer were analyzed.
RESULTS: The numbers of cancer stem cell spheres in group A and B were (1.1±0.2)/1,000 cells and (1.3±0.1)/1,000 cells, respectively, and this had no significant difference (P>0.05). The number of cancer stem cell spheres in group C was (8.6±1.0)/1,000 cells, which was significantly higher than that in group A and B (both P<0.05). The numbers of cancer stem cell spheres in group D and E were (22.4±1.2)/1,000 cells and (17.7±2.0)/1,000 cells, respectively, and this was statistically similar (P>0.05) but either was significantly higher than that in the other three groups (all P<0.05).
CONCLUSIONS: Breast cancer tissues of different molecular subtypes contain varying amounts of cancer stem cells, and this may have certain significance for predicting the prognosis of breast cancer.

Entities:  

Keywords:  Breast neoplasms; molecular subtype; neoplastic stem cells; prognosis

Year:  2012        PMID: 25083423      PMCID: PMC4115715          DOI: 10.3978/j.issn.2227-684X.2012.04.02

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  23 in total

1.  Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways.

Authors:  Ming Li; Deborah A Knight; Mark J Smyth; Trina J Stewart
Journal:  Cancer Immunol Immunother       Date:  2012-01-24       Impact factor: 6.968

Review 2.  Basal phenotype breast cancer: implications for treatment and prognosis.

Authors:  Anastasia Pazaiti; Ian S Fentiman
Journal:  Womens Health (Lond)       Date:  2011-03

3.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 4.  Stem cells in human breast cancer.

Authors:  Lucinei Roberto Oliveira; Stefanie S Jeffrey; Alfredo Ribeiro-Silva
Journal:  Histol Histopathol       Date:  2010-03       Impact factor: 2.303

5.  Endothelial cell differentiation of human breast tumour stem/progenitor cells.

Authors:  Benedetta Bussolati; Cristina Grange; Anna Sapino; Giovanni Camussi
Journal:  J Cell Mol Med       Date:  2009-02       Impact factor: 5.310

Review 6.  The cancer stem cell hypothesis: in search of definitions, markers, and relevance.

Authors:  Michail Shipitsin; Kornelia Polyak
Journal:  Lab Invest       Date:  2008-03-31       Impact factor: 5.662

7.  Retinoid signaling regulates breast cancer stem cell differentiation.

Authors:  Christophe Ginestier; Julien Wicinski; Nathalie Cervera; Florence Monville; Pascal Finetti; François Bertucci; Max S Wicha; Daniel Birnbaum; Emmanuelle Charafe-Jauffret
Journal:  Cell Cycle       Date:  2009-10-10       Impact factor: 4.534

Review 8.  Treatment resistance in stem cells and breast cancer.

Authors:  Bhuvanesh Dave; Jenny Chang
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-03-04       Impact factor: 2.673

9.  Gene expression signatures of morphologically normal breast tissue identify basal-like tumors.

Authors:  Greg Finak; Svetlana Sadekova; Francois Pepin; Michael Hallett; Sarkis Meterissian; Fawaz Halwani; Karim Khetani; Margarita Souleimanova; Brent Zabolotny; Atilla Omeroglu; Morag Park
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

10.  The CD44+/CD24- phenotype is enriched in basal-like breast tumors.

Authors:  Gabriella Honeth; Pär-Ola Bendahl; Markus Ringnér; Lao H Saal; Sofia K Gruvberger-Saal; Kristina Lövgren; Dorthe Grabau; Mårten Fernö; Ake Borg; Cecilia Hegardt
Journal:  Breast Cancer Res       Date:  2008-06-17       Impact factor: 6.466

View more
  2 in total

1.  Karanahan: A Potential New Treatment Option for Human Breast Cancer and Its Validation in a Clinical Setting.

Authors:  Anastasia S Proskurina; Victoria V Kupina; Yaroslav R Efremov; Evgenia V Dolgova; Vera S Ruzanova; Genrikh S Ritter; Ekaterina A Potter; Svetlana S Kirikovich; Evgeniy V Levites; Alexandr A Ostanin; Elena R Chernykh; Oksana G Babaeva; Sergey V Sidorov; Sergey S Bogachev
Journal:  Breast Cancer (Auckl)       Date:  2022-02-14

Review 2.  Prostate Cancer Stem Cells: Research Advances.

Authors:  Dagmara Jaworska; Wojciech Król; Ewelina Szliszka
Journal:  Int J Mol Sci       Date:  2015-11-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.